Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7535171 | 0.89 | — | — | |
| SCHEMBL31259143 | 0.85 | — | — | |
| SCHEMBL8521845 | 0.80 | — | — | |
| SCHEMBL28231867 | 0.79 | MAPK1 (0.32) | MEN1KMT2ACYP3A4MAPK1NPSR1 | |
| SCHEMBL27677591 | 0.79 | — | — | |
| SCHEMBL13157265 | 0.79 | POLB (0.34) | MEN1KMT2A | |
| SCHEMBL28251918 | 0.79 | — | — | |
| SCHEMBL1767501 | 0.78 | CYP3A4 (0.31) | CYP3A4 | |
| SCHEMBL1044296 | 0.78 | CYP3A4 (0.34) | CYP3A4 | |
| SCHEMBL6106227 | 0.78 | NPSR1 (0.31) | NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3468555-B1 | COMPOSITIONS FOR USE IN TREATING BACTERIAL INFECTIONS | VERSITECH LTD (HK) | 2023-08-09 | — | — | EP | disclosed |
| US-7196150-B2 | Method for radical polymerisation in the presence of a chain transfer agent | BASF AKTIENGESELLSCHAFT (DE) | 2007-03-27 | — | — | US | disclosed |
| US-20060058478-A1 | Method for radical polymerisation in the presence of a chain transfer agent | BASF AKTIENGESELLSCHAFT (DE) | 2006-03-16 | — | — | US | disclosed |